History
  • No items yet
midpage
283 A.3d 109
D.C.
2022
Read the full case

Background

  • Center for Inquiry, Inc. (CFI) sued Walmart and CVS under the D.C. Consumer Protection Procedures Act (CPPA), alleging that in-store and online placement and aisle signage (e.g., “Cold, Cough & Flu Relief”) falsely presented homeopathic products as equivalent to science‑based OTC medicines and implied efficacy.
  • The Superior Court dismissed both complaints for lack of standing (CFI did not qualify as a CPPA “public interest organization”) and for failure to state a claim, reasoning that product placement and labels made by manufacturers were not actionable misrepresentations as a matter of law.
  • CFI appealed; the D.C. Court of Appeals consolidated the appeals and reviewed standing and dismissal de novo.
  • The court applied the three-part test from Animal Legal Defense Fund v. Hormel for §28‑3905(k)(1)(D) public-interest organization standing: (1) organization status, (2) identification of a consumer/class that could sue, and (3) sufficient nexus to those consumers’ interests.
  • The Court of Appeals held CFI has standing: CFI’s mission and sustained advocacy against homeopathy (petitions, comments to FDA/FTC, publicity) show it is a nonprofit organized and operating, at least in part, to promote consumers’ interests; it identified D.C. consumers as the relevant class and has a sufficient nexus to represent them.
  • On the merits the appellate court held product placement and aisle signage can constitute a "representation" or misleading innuendo under the CPPA, and whether the placement has a tendency to mislead reasonable consumers is a fact question for a jury; the dismissals were reversed and the cases remanded.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Standing as a public‑interest organization under §28‑3905(k)(1)(D) CFI’s mission and sustained activities opposing homeopathy show it is organized/operating to promote consumer interests and has nexus to D.C. consumers CFI lacks a consumer‑focused mission and specific nexus to consumers; no nonprofit standing shown CFI has standing: meets the three‑box ALDF test (organization, identifiable consumer class, sufficient nexus)
Whether product placement/signage can be a “representation” under the CPPA Placement and signage beside science‑based drugs imply equivalence/efficacy and therefore are representations/innuendo Placement is not a communicative representation of efficacy and is not actionable Product placement and associated signage can be actionable representations or innuendo under the CPPA
Whether the complaint plausibly alleges a tendency to mislead reasonable consumers (failure‑to‑state claim) Photos, aisle signs, placement, and public records (FTC statements) plausibly show consumers may infer efficacy/equivalence Allegations are conclusory and lack facts showing consumers are actually or likely deceived Allegations are plausible; tendency‑to‑mislead is a jury question and dismissal at pleading stage was premature
Pleading standard at motion to dismiss (Twombly/Iqbal context) Complaint contains factual allegations and public‑agency materials sufficient to nudge claim past plausibility Plaintiff must plead more concrete evidence (e.g., specific deceived consumers) Twombly/Iqbal govern, but CFI’s factual allegations and public record meet plausibility for discovery and trial preparation

Key Cases Cited

  • Animal Legal Defense Fund v. Hormel, 258 A.3d 174 (D.C. 2021) (articulates three‑part test for CPPA public‑interest organization standing)
  • Saucier v. Countrywide Home Loans, 64 A.3d 428 (D.C. 2013) (reasonable‑consumer standard; CPPA construed liberally as remedial)
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility pleading standard for Rule 12(b)(6))
  • Ashcroft v. Iqbal, 556 U.S. 662 (clarifies Twombly plausibility inquiry)
  • Williams v. Gerber Prods. Co., 552 F.3d 934 (9th Cir. 2008) (deceptiveness usually a question for the jury)
  • Bell v. Publix Super Markets, Inc., 982 F.3d 468 (7th Cir. 2020) (reasonable consumer does not parse fine print; deceptive‑ness is typically for the factfinder)
  • 1‑800 Contacts, Inc. v. WhenU.Com, Inc., 414 F.3d 400 (2d Cir. 2005) (recognizes product placement can influence consumer choice)
Read the full case

Case Details

Case Name: Center for Inquiry, Inc. v. Walmart, Inc. & Center for Inquiry, Inc. v. CVS Pharmacy, Inc.
Court Name: District of Columbia Court of Appeals
Date Published: Sep 29, 2022
Citations: 283 A.3d 109; 20-CV-392 & 20-CV-530
Docket Number: 20-CV-392 & 20-CV-530
Court Abbreviation: D.C.
Log In
    Center for Inquiry, Inc. v. Walmart, Inc. & Center for Inquiry, Inc. v. CVS Pharmacy, Inc., 283 A.3d 109